Evaluating Minimal Clinically Important Differences for the Acne-Specific Quality of Life Questionnaire

PharmacoEconomics

Volumn 21, Issue 15, 2003, Pages 1069-1079

  McLeod, Lori D ^a   Fehnel, Sheri E ^a   Brandman, Jane ^c   Symonds, Tara ^b  

^a RTI HEALTH SOLUTIONS   (United States)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ETHINYLESTRADIOL PLUS NORETHISTERONE ACETATE; ORAL CONTRACEPTIVE AGENT;

ACNE; ACNE VULGARIS; ADULT; ANALYTIC METHOD; ARTICLE; CLINICAL EXAMINATION; CLINICAL MEDICINE; CLINICAL SIGNIFICANCE; CLINICAL TRIAL; DRUG EFFICACY; EMOTION; EVALUATION; FEMALE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MINIMAL CLINICALLY IMPORTANT DIFFERENCE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SELF CONCEPT; SELF EVALUATION; SOCIAL ASPECT; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY;

ACNE VULGARIS; ADOLESCENT; ADULT; CONTRACEPTIVES, ORAL, COMBINED; ETHINYL ESTRADIOL; FEMALE; HUMANS; MIDDLE AGED; NORETHINDRONE; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; SELF CONCEPT; SICKNESS IMPACT PROFILE; TREATMENT OUTCOME;

EID: 0142186053     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-200321150-00001     Document Type: Article

References (12)

1. Layton AM. Psychological aspects of acne vulgaris. J Cutan Med Surg 1998; 2: 19-23
2. Jaeschke R, Singer J, Guyatt G. Measurement of health status: ascertaining the minimal clinically important difference. Control Clin Trials 1989; 10: 407-15
3. Maloney JM, Arbit DI, Flack M, et al. Use of a low-dose oral contraceptive containing norethindrone acetate and ethinyl estradiol in the treatment of moderate acne vulgaris. Clin J Womens Health 2001; 1: 123-31
4. Girman CJ, Hartmaier S, Thiboutout D, et al. Evaluating health-related quality of life in patients with facial acne: development of a self-administered questionnaire for clinical trials. Qual Life Res 1996; 5: 481-90
5. Martin AR, Lookingbill DP, Botek A, et al. Health-related quality of life among patients with facial acne: assessment of a new acne-specific questionnaire. Clin Exp Dermatol 2001 Jul; 26 (5): 380-5
6. Fehnel SE, McLeod LD, Brandman J, et al. Responsiveness of the Acne-Specific Quality of Life Questionnaire (Acne-QoL) to treatment for acne vulgaris in placebo-controlled clinical trials. Qual Life Res 2002 Dec; 11 (8): 809-16
7. Juniper EF, Guyatt GH, Willan A, et al. Determining a minimal important change in a disease-specific quality of life questionnaire. J Clin Epidemiol 1994; 47: 81-7
8. Osoba D, Rodrigues G, Myles J, et al. Interpreting the significance of changes in health related quality of life scores. J Clin Oncol 1998; 16: 139-44
9. Jones PW and the Nedocromil Sodium Quality of Life Study Group. Quality of life, symptoms and pulmonary function in asthma: long term treatment with nedocromil sodium examined in a controlled multicentre trail. Eur Respir J 1994; 7: 55-62
10. Norman GR, Sridhar FG, Guyatt GH, et al. Relation of distribution-and anchor-based approaches in interpretation of changes in health related quality of life. Med Care 2001; 39: 1039-47
11. Guyatt GH, Juniper EF, Walter SD, et al. Interpreting treatment effects in randomized trails. BMJ 1998; 316: 690-2
12. Cohen J. Statistical power: analysis for the behavioral sciences. New York: Academic Press, 1977